Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's ... (a novel method of ventricular measuremen...)

HOME >> MEDICINE >> TECHNOLOGY

Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's Treatments

Date:4/30/2009

a novel method of ventricular measurement that accurately reflects brain atrophy," said James Paskavitz, M.D., Medical Director, Perceptive Informatics. "We believe that this method can support sponsors in reducing the time, cost, and risk associated with clinical development of Alzheimer's treatments by providing medical image data that informs early phase decisions and is reproducible for later phase, multi-center trials."

The Perceptive Informatics Medical Imaging Group has helped to develop and validate novel surrogate endpoints for a variety of CNS disorders. Perceptive offers a range of capabilities in the application of imaging techniques from early clinical development through late phase studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology imaging.

More information about the Medical Imaging capabilities provided by Perceptive Informatics is available at http://www.perceptive.com/product/imaging/index-medical-imaging.html.

ADNI is focused on defining the rate of progress of mild cognitive impairment and Alzheimer's disease, developing improved methods for clinical trials in this area, and providing a large database to improve design of treatment trials. A goal of ADNI is to provide information and methods to help lead to effective treatments for Alzheimer's disease, leading to effective prevention. More information about ADNI can be found at http://www.adni-info.org.

About Perceptive Informatics

Perceptive
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
2. Siemens Introduces New Standard of Care for Breast Ultrasound
3. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
4. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
7. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
8. Dr. Dello Russo Introduces the New EYE-Q Lasik
9. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
10. Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
11. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

Post Your Comments:

(Date:12/15/2009)... Genomic Health, Inc. (Nasdaq: GHDX ) ... Onco type DX® breast cancer test, a multi-gene ... likelihood of chemotherapy benefit and recurrence risk for patients ... the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, ... TX. ,, "The breadth of data presented at last ...

(Date:12/15/2009)... Arlington Medical Resources (AMR) and Decision ... (MRSA) is the most concerning pathogen to surveyed ... treatment of skin and skin structure infections. A ... factors that influences European physician drug selection for ... factors that drive prescribing include an agent,s skin ...

(Date:12/15/2009)... INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... ), Eli Lilly and Company (NYSE: ... ) today announced positive results from a head-to-head ... therapy, to BYETTA® (exenatide) injection taken twice daily, ... weeks of treatment, patients taking exenatide once weekly ...

Breaking Medicine Technology:Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7 Study Forecasts More Young Doctors in Future 59852 1 Study Forecasts More Young Doctors in Future 59852 2 Experimental treatments restore partial vision to blind people 10444 1 Experimental treatments restore partial vision to blind people 10444 2 Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 1 Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 2

[0] Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study

... Drugs on the Market and, in Clinical Development with Each ... Anticancer Effects, and Expand the Markets for ... ... Identification of novel,cancer-related targets and pathways is redefining our understanding of ...

... Mich., Feb. 19 Compendia Bioscience, Inc.,today announced ... renewed,and expanding commitment from all major customers and ... to its customer roster. The new,customers and existing ... revenue increase, with similar growth forecasted for 2008., ...

Other Medicine Technology:Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 2 Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 3 Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 4 On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2 On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3

Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments

(Date:12/14/2009)... Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and Related ... Nearly all unmarried young adults ages 18-29 believe pregnancy ... and 86% of women) and say that it is ... (86% of men and 88% of women), according to ... Teen and Unplanned Pregnancy. Even so: ,, ...

(Date:12/14/2009)... oxygen, drugs, and more… , ... ... in collaboration with scientists at University of Michigan, have developed ... of natural red blood cells, including softness, flexibility, and the ... primary function of natural red blood cells is to carry ...

(Date:12/14/2009)... ARBOR, Mich., Dec. 14 Pepsi ... the Commonwealth of Kentucky are among the major ... this fall to help their employees make better ... solution gives employees a personalized summary of their ... of that care. With this personalized information, employees ...

(Date:12/14/2009)... -- Americold Realty Trust ("Americold") announced today that it ... the U.S. Securities and Exchange Commission (the "SEC") relating ... shares. The number of shares to be offered and ... been determined. The common shares to be sold in ... ,, The joint book-running managers of the offering ...

(Date:12/14/2009)... BRAINTREE, Mass., Dec. 14 Haemonetics Corporation ... it has filed a new legal action to ... Fenwal,s just released red cell collection kits, using ... its separation chamber to circumvent Haemonetics, patent and ... continued sale of infringing products after December 1, ...

Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2 Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3 Health News:Synthetic Red Blood Cells Developed 2 Health News:Synthetic Red Blood Cells Developed 3 Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2 Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3

[1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference [0] Synthetic Red Blood Cells Developed [0] Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process [0] Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering [0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement

... SAN DIEGO, Nov. 24 Volcano Corporation (Nasdaq: VOLC ... for the diagnosis and treatment of coronary and peripheral artery disease, ... Piper Jaffray Health Care Conference on Tuesday, December 2. , ... and chief executive officer, will begin at 1:30 p.m., Eastern Standard ...

... Calif., Nov. 24 Thoratec Corporation,(Nasdaq: THOR ... to save, support and restore falling hearts, said today ... Jaffray Heath Care Conference on,Wednesday, December 3. , ... provide an,update on the company, beginning at 1 p.m., ...

... Networks, Inc.(TM), the,company delivering new technology in enterprise ... Networks executive Amit Chawla as its new President,and ... Agito Networks, flagship product is the ... IP telephony, and,location information, improving the accessibility and ...

... Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of ... , King Extends Tender Offer Through December 19, 2008 ... BRIDGEWATER, N.J., Nov. 24 King Pharmaceuticals, Inc. (NYSE: ... announced that the two companies have signed a definitive merger agreement ...

... with Broad Potential to Treat Life-Threatening Viral Infections-- , ... and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models-- ... is a ,Druggable, Target Common to a Number of Serious ... Calif., Nov. 24 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) ...

... summarized- , , ... Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian ... Cell Wall-DNA Complex (MCC) - trademarked Urocidin - ... 2008 Societe Internationale d,Urologie (SIU) Congress in Santiago, ...

Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast Thoratec Presentation at Piper Jaffary Conference to be Webcast Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile

For the quantitative determination of uric acid in serum....

... new level of immunodiagnostic productivity. Optimal flexibility. ... laboratory automation system. No-pause loading of all ... only immunoassay system with this capability. No ... without any additional setup. Continuous sample loading. ...

... Engineered for continuous, random access operation, the ... medium to large volume laboratories that want ... offers the simplicity, flexibility and Stat capabilities ... can be adapted to the changing needs ...

The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...

Medicine Products:

Uric Acid Reagent Set Advia Centaur Elecsys 2010 Disk System Dimension RxL Max w/o HM 50/60 HZ

Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's ...(a novel method of ventricular measuremen...),Health